Speak to a scientist

1 + 2 =

Breakthrough bioanalysis

Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides and biomarkers.

Enabling rapid drug development

Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means fewer complications helping the rapid development of new drugs.

We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report.

As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today.


Alderley Analytical Christmas Bake-Off for Charity

Alderley Analytical Christmas Bake-Off for Charity

What do bioanalysts do when not bioanalysing? They have a company-wide, Christmas bake-off for a good cause! Our baking competition is in support of our nominated charity, The East Cheshire Hospice. The East Cheshire Hospice provides...

read more

Our clients

‘The right quality data and reports on time, every time, just how we like it.’

Medium sized pharma, UK

‘A fantastic service, very reactive to our change in project needs and a “can do” attitude.’

Small Pharma, Western Europe

‘A great team to work with, delivery focused and provide quality data.’

In vivo service provider, UK

‘Just a note to say we’ve been very impressed by the efficiency of Alderley Analytical for this project.’

Top 10 pharma, US